Selected research
Market Structure
Global Embolotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Embolotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Embolotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Embolotherapy include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian and Stryker, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Embolotherapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Embolotherapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Embolotherapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Embolotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.
Embolotherapy Segment by Company
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology
Embolotherapy Segment by Type
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others
Embolotherapy Segment by Application
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others
Embolotherapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Embolotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Embolotherapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Embolotherapy industry.
Chapter 3: Detailed analysis of Embolotherapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Embolotherapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Microspheres for Embolization
- Embolism Particles
- Embolic coils
- Liquid Embolic Agent
- Auxiliary Embolization Material
- Others
Applications
- Cancer
- Peripheral Aascular Disease
- Nerve System Disease
- Others
Companies covered
- Medtronic
- Boston Scientific
- Terumo
- Penumbra, Inc.
- Johnson & Johnson
- Sirtex
- Merit Medical
- Varian
- Stryker
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- Cook Medical
- Kaneka
- Meril Life Sciences
- Peijia Medical Limited
- Wallaby Medical
- MicroPort Scientific Corporation
- Shandong Visee Medical Devices Co.,Ltd
- Beijing Taijie Weiye Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Embolotherapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Microspheres for Embolization
- 1.2.3 Embolism Particles
- 1.2.4 Embolic coils
- 1.2.5 Liquid Embolic Agent
- 1.2.6 Auxiliary Embolization Material
- 1.2.7 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Embolotherapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Cancer
- 1.3.3 Peripheral Aascular Disease
- 1.3.4 Nerve System Disease
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Embolotherapy Growth Trends by Region
- 1.5.1 Global Embolotherapy Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Embolotherapy Market Size by Region (2021-2026)
- 1.5.3 Embolotherapy Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Embolotherapy Market Dynamics
- 2.1 Embolotherapy Industry Trends
- 2.2 Embolotherapy Industry Drivers
- 2.3 Embolotherapy Industry Opportunities and Challenges
- 2.4 Embolotherapy Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Embolotherapy Revenue by Company (2021-2026)
- 3.2 Global Embolotherapy Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Embolotherapy Key Company Head office and Area Served
- 3.4 Global Embolotherapy Company, Product Type & Application
- 3.5 Global Embolotherapy Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Embolotherapy Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Embolotherapy Players Market Share by Revenue in 2025
- 3.6.3 2025 Embolotherapy Tier 1, Tier 2, and Tier 3
4 Embolotherapy Market by Type
- 4.1 Global Embolotherapy Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Embolotherapy Market Size by Type (2021-2032)
- 4.3 Global Embolotherapy Market Size Share by Type (2021-2032)
5 Embolotherapy Market by Application
- 5.1 Global Embolotherapy Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Embolotherapy Market Size by Application (2021-2032)
- 5.3 Global Embolotherapy Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Medtronic Embolotherapy Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Boston Scientific
- 6.2.1 Boston Scientific Company Information
- 6.2.2 Boston Scientific Business Overview
- 6.2.3 Boston Scientific Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Boston Scientific Embolotherapy Product Portfolio
- 6.2.5 Boston Scientific Recent Developments
- 6.3 Terumo
- 6.3.1 Terumo Company Information
- 6.3.2 Terumo Business Overview
- 6.3.3 Terumo Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Terumo Embolotherapy Product Portfolio
- 6.3.5 Terumo Recent Developments
- 6.4 Penumbra, Inc.
- 6.4.1 Penumbra, Inc. Company Information
- 6.4.2 Penumbra, Inc. Business Overview
- 6.4.3 Penumbra, Inc. Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Penumbra, Inc. Embolotherapy Product Portfolio
- 6.4.5 Penumbra, Inc. Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Company Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Johnson & Johnson Embolotherapy Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 6.6 Sirtex
- 6.6.1 Sirtex Company Information
- 6.6.2 Sirtex Business Overview
- 6.6.3 Sirtex Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Sirtex Embolotherapy Product Portfolio
- 6.6.5 Sirtex Recent Developments
- 6.7 Merit Medical
- 6.7.1 Merit Medical Company Information
- 6.7.2 Merit Medical Business Overview
- 6.7.3 Merit Medical Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Merit Medical Embolotherapy Product Portfolio
- 6.7.5 Merit Medical Recent Developments
- 6.8 Varian
- 6.8.1 Varian Company Information
- 6.8.2 Varian Business Overview
- 6.8.3 Varian Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Varian Embolotherapy Product Portfolio
- 6.8.5 Varian Recent Developments
- 6.9 Stryker
- 6.9.1 Stryker Company Information
- 6.9.2 Stryker Business Overview
- 6.9.3 Stryker Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Stryker Embolotherapy Product Portfolio
- 6.9.5 Stryker Recent Developments
- 6.10 Jiangsu Hengrui Pharmaceuticals Co., Ltd
- 6.10.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Company Information
- 6.10.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
- 6.10.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Embolotherapy Product Portfolio
- 6.10.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
- 6.11 Cook Medical
- 6.11.1 Cook Medical Company Information
- 6.11.2 Cook Medical Business Overview
- 6.11.3 Cook Medical Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Cook Medical Embolotherapy Product Portfolio
- 6.11.5 Cook Medical Recent Developments
- 6.12 Kaneka
- 6.12.1 Kaneka Company Information
- 6.12.2 Kaneka Business Overview
- 6.12.3 Kaneka Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Kaneka Embolotherapy Product Portfolio
- 6.12.5 Kaneka Recent Developments
- 6.13 Meril Life Sciences
- 6.13.1 Meril Life Sciences Company Information
- 6.13.2 Meril Life Sciences Business Overview
- 6.13.3 Meril Life Sciences Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Meril Life Sciences Embolotherapy Product Portfolio
- 6.13.5 Meril Life Sciences Recent Developments
- 6.14 Peijia Medical Limited
- 6.14.1 Peijia Medical Limited Company Information
- 6.14.2 Peijia Medical Limited Business Overview
- 6.14.3 Peijia Medical Limited Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Peijia Medical Limited Embolotherapy Product Portfolio
- 6.14.5 Peijia Medical Limited Recent Developments
- 6.15 Wallaby Medical
- 6.15.1 Wallaby Medical Company Information
- 6.15.2 Wallaby Medical Business Overview
- 6.15.3 Wallaby Medical Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Wallaby Medical Embolotherapy Product Portfolio
- 6.15.5 Wallaby Medical Recent Developments
- 6.16 MicroPort Scientific Corporation
- 6.16.1 MicroPort Scientific Corporation Company Information
- 6.16.2 MicroPort Scientific Corporation Business Overview
- 6.16.3 MicroPort Scientific Corporation Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 MicroPort Scientific Corporation Embolotherapy Product Portfolio
- 6.16.5 MicroPort Scientific Corporation Recent Developments
- 6.17 Shandong Visee Medical Devices Co.,Ltd
- 6.17.1 Shandong Visee Medical Devices Co.,Ltd Company Information
- 6.17.2 Shandong Visee Medical Devices Co.,Ltd Business Overview
- 6.17.3 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Shandong Visee Medical Devices Co.,Ltd Embolotherapy Product Portfolio
- 6.17.5 Shandong Visee Medical Devices Co.,Ltd Recent Developments
- 6.18 Beijing Taijie Weiye Technology
- 6.18.1 Beijing Taijie Weiye Technology Company Information
- 6.18.2 Beijing Taijie Weiye Technology Business Overview
- 6.18.3 Beijing Taijie Weiye Technology Embolotherapy Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Beijing Taijie Weiye Technology Embolotherapy Product Portfolio
- 6.18.5 Beijing Taijie Weiye Technology Recent Developments
7 North America
- 7.1 North America Embolotherapy Market Size (2021-2032)
- 7.2 North America Embolotherapy Market Size by Type
- 7.2.1 North America Embolotherapy Market Size by Type (2021-2026)
- 7.2.2 North America Embolotherapy Market Size by Type (2027-2032)
- 7.2.3 North America Embolotherapy Market Share by Type (2021-2032)
- 7.3 North America Embolotherapy Market Size by Application
- 7.3.1 North America Embolotherapy Market Size by Application (2021-2026)
- 7.3.2 North America Embolotherapy Market Size by Application (2027-2032)
- 7.3.3 North America Embolotherapy Market Share by Application (2021-2032)
- 7.4 North America Embolotherapy Market Size by Country
- 7.4.1 North America Embolotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Embolotherapy Market Size by Country (2021-2026)
- 7.4.3 North America Embolotherapy Market Size by Country (2027-2032)
- 7.4.4 North America Embolotherapy Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Embolotherapy Market Size (2021-2032)
- 8.2 Europe Embolotherapy Market Size by Type
- 8.2.1 Europe Embolotherapy Market Size by Type (2021-2026)
- 8.2.2 Europe Embolotherapy Market Size by Type (2027-2032)
- 8.2.3 Europe Embolotherapy Market Share by Type (2021-2032)
- 8.3 Europe Embolotherapy Market Size by Application
- 8.3.1 Europe Embolotherapy Market Size by Application (2021-2026)
- 8.3.2 Europe Embolotherapy Market Size by Application (2027-2032)
- 8.3.3 Europe Embolotherapy Market Share by Application (2021-2032)
- 8.4 Europe Embolotherapy Market Size by Country
- 8.4.1 Europe Embolotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Embolotherapy Market Size by Country (2021-2026)
- 8.4.3 Europe Embolotherapy Market Size by Country (2027-2032)
- 8.4.4 Europe Embolotherapy Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Embolotherapy Market Size (2021-2032)
- 9.2 China Embolotherapy Market Size by Type
- 9.2.1 China Embolotherapy Market Size by Type (2021-2026)
- 9.2.2 China Embolotherapy Market Size by Type (2027-2032)
- 9.2.3 China Embolotherapy Market Share by Type (2021-2032)
- 9.3 China Embolotherapy Market Size by Application
- 9.3.1 China Embolotherapy Market Size by Application (2021-2026)
- 9.3.2 China Embolotherapy Market Size by Application (2027-2032)
- 9.3.3 China Embolotherapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Embolotherapy Market Size (2021-2032)
- 10.2 Asia Embolotherapy Market Size by Type
- 10.2.1 Asia Embolotherapy Market Size by Type (2021-2026)
- 10.2.2 Asia Embolotherapy Market Size by Type (2027-2032)
- 10.2.3 Asia Embolotherapy Market Share by Type (2021-2032)
- 10.3 Asia Embolotherapy Market Size by Application
- 10.3.1 Asia Embolotherapy Market Size by Application (2021-2026)
- 10.3.2 Asia Embolotherapy Market Size by Application (2027-2032)
- 10.3.3 Asia Embolotherapy Market Share by Application (2021-2032)
- 10.4 Asia Embolotherapy Market Size by Country
- 10.4.1 Asia Embolotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Embolotherapy Market Size by Country (2021-2026)
- 10.4.3 Asia Embolotherapy Market Size by Country (2027-2032)
- 10.4.4 Asia Embolotherapy Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Embolotherapy Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Embolotherapy Market Size by Type
- 11.2.1 South America, Middle East & Africa Embolotherapy Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Embolotherapy Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Embolotherapy Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Embolotherapy Market Size by Application
- 11.3.1 South America, Middle East & Africa Embolotherapy Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Embolotherapy Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Embolotherapy Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Embolotherapy Market Size by Country
- 11.4.1 South America, Middle East & Africa Embolotherapy Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Embolotherapy Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Embolotherapy Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Embolotherapy Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst